European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, falling 0.9% to 1,901.24 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and medical device maker EDAP TMS (FOCL), which rose 5.3% and 4.4% respectively. They were followed by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which were up 3.7% and 2.1% respectively.

The decliners from continental Europe were led by biopharmaceutical company Grifols (GRFS) and lender Banco Santander (SAN), which dropped 4.2% and 3.6% respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and accommodations booking site trivago (TRVG), which lost 3.1% and 2.9% respectively.

The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group (MREO) and oil and gas company BP (BP), which advanced 2.8% and 2.3% respectively. They were followed by oil and gas company Shell (SHEL), which increased 1.6%.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and tobacco company British American Tobacco (BTI), which fell 5.4% and 3.3% respectively. They were followed by alcoholic beverage company Diageo (DEO) and educational publisher Pearson (PSO), which were down 2.4% and 0.4% respectively.